Related Experiment Video

Updated: Jul 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Statin therapy and contrast-induced nephropathy after primary angioplasty

Alberto Bouzas-Mosquera, José M Vázquez-Rodríguez, Ramón Calviño-Santos

    International Journal of Cardiology
    |May 10, 2008
    PubMed

    Insights

    Statin therapy did not prevent contrast-induced nephropathy (CIN) in patients undergoing primary angioplasty for acute myocardial infarction. This study found no significant difference in CIN incidence between statin users and non-users.

    Area of Science:

    • Cardiology
    • Nephrology
    • Pharmacology

    Background:

    • Contrast-induced nephropathy (CIN) is a complication following percutaneous coronary intervention.
    • Previous studies suggested statins might offer protection against CIN.
    • This study aimed to validate these findings in a larger patient cohort.

    Discussion:

    • The incidence of CIN was 11.9% in the overall study population.
    • Patients on statin therapy had a CIN incidence of 15.9%, versus 10.8% in those not on statins.
    • The observed difference in CIN rates between the groups was not statistically significant (p=0.2).

    Key Insights:

    • Statin therapy did not demonstrate a statistically significant protective effect against CIN in patients undergoing primary angioplasty.
    • The study did not confirm previous suggestions of statins preventing CIN in this specific clinical setting.
    • Larger, prospective studies may be needed to definitively establish the role of statins in CIN prevention.

    Outlook:

    • Further research is warranted to explore alternative strategies for CIN prevention.
    • Investigating the impact of different statin types and dosages on CIN risk could be beneficial.
    • Understanding the underlying mechanisms of CIN is crucial for developing targeted therapies.

    More Related Videos

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

    Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

    Published on: August 26, 2025

    Related Concept Videos

    Cardiac Catheterization I: Pre-Procedure Overview01:28

    Cardiac Catheterization I: Pre-Procedure Overview

    Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
    Imaging Studies VII: Vascular Imaging01:19

    Imaging Studies VII: Vascular Imaging

    DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
    Coronary Artery Disease V: Interprofessional Care01:27

    Coronary Artery Disease V: Interprofessional Care

    Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
    Acute Coronary Syndrome IV: Interprofessional Care01:28

    Acute Coronary Syndrome IV: Interprofessional Care

    IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...